These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38592657)

  • 1. Behind the Scenes: A Qualitative Investigation of Interviewers' Performance in EQ-5D Valuation Studies.
    Varriale C; Andrulli G; Meregaglia M; Rencz F; Finch AP
    Pharmacoecon Open; 2024 May; 8(3):389-401. PubMed ID: 38592657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?
    Yang Z; van Busschbach J; Timman R; Janssen MF; Luo N
    PLoS One; 2017; 12(9):e0184883. PubMed ID: 28934266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration.
    Finch AP; Meregaglia M; Ciani O; Roudijk B; Jommi C
    Soc Sci Med; 2022 Jan; 292():114519. PubMed ID: 34736804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality Control Process for EQ-5D-5L Valuation Studies.
    Ramos-Goñi JM; Oppe M; Slaap B; Busschbach JJ; Stolk E
    Value Health; 2017 Mar; 20(3):466-473. PubMed ID: 28292492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection.
    Purba FD; Hunfeld JA; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJ
    Qual Life Res; 2017 May; 26(5):1197-1208. PubMed ID: 27796774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.
    Ludwig K; von der Schulenburg JG; Greiner W
    Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EQ-5D-5L Valuation Study in Egypt.
    Al Shabasy S; Abbassi M; Finch A; Roudijk B; Baines D; Farid S
    Pharmacoeconomics; 2022 Apr; 40(4):433-447. PubMed ID: 34786590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EQ-5D-5L Valuation Study in Egypt.
    Al Shabasy SA; Abbassi MM; Finch AP; Baines D; Farid SF
    Pharmacoeconomics; 2021 May; 39(5):549-561. PubMed ID: 33709283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.
    Al Shabasy S; Abbassi M; Farid S
    BMJ Open; 2021 Dec; 11(12):e051727. PubMed ID: 34949616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
    Jyani G; Yang Z; Sharma A; Goyal A; Stolk E; Purba FD; Grover S; Kaur M; Prinja S
    Med Decis Making; 2023 Aug; 43(6):692-703. PubMed ID: 37480281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.
    Oppe M; Rand-Hendriksen K; Shah K; Ramos-Goñi JM; Luo N
    Pharmacoeconomics; 2016 Oct; 34(10):993-1004. PubMed ID: 27084198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Interviewers' Evaluations of Respondents' Performance in Telephone Interviews: Behavior, Response Quality Indicators, and Characteristics of Respondents and Interviewers.
    Garbarski D; Dykema J; Schaeffer NC; Jones CP; Neman TS; Edwards DF
    Public Opin Q; 2023; 87(Suppl 1):480-506. PubMed ID: 37705920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.
    Oppe M; Devlin NJ; van Hout B; Krabbe PF; de Charro F
    Value Health; 2014 Jun; 17(4):445-53. PubMed ID: 24969006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.
    Xie F; Gaebel K; Perampaladas K; Doble B; Pullenayegum E
    Med Decis Making; 2014 Jan; 34(1):8-20. PubMed ID: 23525701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain.
    Estévez-Carrillo A; Dewilde S; Oppe M; Ramos-Goñi JM
    Patient; 2022 Sep; 15(5):521-535. PubMed ID: 35169979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned.
    Al Shabasy S; Roudijk B; Abbassi M; Finch A; Stolk E; Farid S
    Pharmacoeconomics; 2023 Mar; 41(3):329-338. PubMed ID: 36434416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study.
    Al-Jedai A; Almudaiheem H; Al-Salamah T; Aldosari M; Almutairi AR; Almogbel Y; AlRuthia Y; Althemery AU; Alluhidan M; Roudijk B; Purba FD; Awad N; O'jeil R
    Value Health; 2024 May; 27(5):552-561. PubMed ID: 38342365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.